Market Overview

Editas Medicine (NASDAQ:EDIT) Press Releases

Wednesday, January 20, 2021

Editas Medicine Announces Pricing of Offering of Common Stock (EDIT, Markets, Press Releases / Wed, 10:30pm)

Tuesday, January 19, 2021

Editas Medicine Announces Offering of Common Stock (EDIT, Press Releases / Tue, 04:01pm)

Monday, January 11, 2021

Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference (EDIT, Press Releases / Mon, 06:05am)
Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical Trial (EDIT, Press Releases / Mon, 06:02am)
Editas Medicine Announces Transition of Chief Scientific Officer (EDIT, News, Management, Press Releases / Mon, 06:00am)

Monday, January 04, 2021

Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference (EDIT, News, Press Releases / Mon, 04:05pm)

Tuesday, December 22, 2020

Thinking about trading options or stock in Apple, Peloton, FuelCell Energy, Editas Medicine, or Goldman Sachs? (AAPL, EDIT, FCEL, GS, PTON, Opinion, Press Releases / Tue, 09:31am)

Thursday, December 17, 2020

Editas Medicine Names Meeta Chatterjee, Ph.D., to Board of Directors (EDIT, News, Management, Press Releases / Thu, 04:05pm)

Wednesday, December 09, 2020

Editas Medicine Announces Submission of IND Application for EDIT-301 with the FDA (EDIT, Health Care, Press Releases, General / Wed, 04:01pm)

Saturday, December 05, 2020

Editas Medicine Announces Preclinical Data and Large-Scale Manufacturing Process for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia (EDIT, Health Care, Press Releases / Sat, 10:00am)

Tuesday, November 10, 2020

Editas Medicine Reports Inducement Grants to New Chief Medical Officer (EDIT, Press Releases / Tue, 04:01pm)

Monday, November 09, 2020

Editas Medicine to Present at Barclays Gene Editing & Gene Therapy Summit (EDIT, News, Press Releases / Mon, 04:05pm)
Editas Medicine Appoints Lisa A. Michaels, M.D., as Chief Medical Officer (EDIT, Press Releases / Mon, 09:00am)

Thursday, November 05, 2020

Editas Medicine, Inc. to Host Earnings Call (Earnings, EDIT, News, Press Releases / Thu, 04:15pm)
Editas Medicine Announces Third Quarter 2020 Results and Update (Earnings, EDIT, News, Press Releases / Thu, 04:02pm)

Thursday, October 29, 2020

Editas Medicine to Host Conference Call Discussing Third Quarter 2020 Results and Corporate Update (EDIT, News, Press Releases / Thu, 03:01pm)

Thursday, October 01, 2020

Editas Medicine to Participate in Upcoming Investor Conference (EDIT, News, Press Releases / Thu, 07:00am)

Friday, September 11, 2020

Editas Medicine Announces U.S. Patent and Trademark Office Grants the Broad Institute Priority Benefit in CRISPR Interference (EDIT, News, Legal, Press Releases / Fri, 06:00am)

Friday, September 04, 2020

Editas Medicine to Participate in Upcoming Investor Conferences (EDIT, News, Press Releases / Fri, 07:00am)

Monday, August 24, 2020

Editas Medicine Receives Rare Pediatric Disease Designation for EDIT-301 for the Treatment of Sickle Cell Disease (EDIT, Press Releases, General / Mon, 07:30am)

Thursday, August 06, 2020

Editas Medicine Announces Second Quarter 2020 Results and Update (Earnings, EDIT, Press Releases / Thu, 03:05pm)
Editas Medicine Regains Full Global Rights to Ocular Medicines (EDIT, Health Care, Press Releases, General / Thu, 03:01pm)

Wednesday, July 29, 2020

Monday, July 27, 2020

Editas Medicine Appoints Gad Berdugo as Chief Business Officer (EDIT, News, Management, Press Releases / Mon, 03:01pm)

Thursday, July 23, 2020

Editas Medicine to Host Conference Call Discussing Second Quarter 2020 Results and Corporate Update (EDIT, News, Press Releases / Thu, 03:01pm)

Tuesday, July 07, 2020

Friday, June 26, 2020

Editas Medicine Announces Closing of Offering of Common Stock and Full Exercise by Underwriter of Option to Purchase Additional Shares (EDIT, News, Financing, Markets, Press Releases / Fri, 03:05pm)

Tuesday, June 23, 2020

Editas Medicine Announces Pricing of Offering of Common Stock (EDIT, News, Financing, Markets, Press Releases / Tue, 08:48pm)
Editas Medicine Announces Offering of Common Stock (EDIT, Markets, Press Releases / Tue, 03:21pm)

Friday, June 12, 2020

Editas Medicine Presents Pre-Clinical Data from a Study of EDIT-301 with Sickle Patient Cells for the Potential Treatment of Sickle Cell Disease (EDIT, Health Care, Press Releases / Fri, 05:00am)

Friday, May 15, 2020

Editas Medicine Presents Pre-Clinical Data Supporting the use of CRISPR-Cas12a to Edit Induced Pluripotent Stem Cells for the Development of Engineered Cell Immunotherapies (EDIT, Health Care, Press Releases / Fri, 08:20am)

Thursday, May 07, 2020

Editas Medicine Announces First Quarter 2020 Results and Update (EDIT, Press Releases / Thu, 06:00am)

Thursday, April 30, 2020

Editas Medicine to Host Conference Call Discussing First Quarter 2020 Results and Corporate Update (EDIT, News, Press Releases / Thu, 07:05am)

1	GME, PLTR: Here's Why Nio, Alibaba, Palantir And GameStop Are Moving
2	BB, SNOW: 'Peak Stupidity': The End Of The GameStop Short Squee...
3	PPSI, EXPR: 40 Stocks Moving in Monday's Pre-Market Session
4	GOOG, GOOGL: Tesla 'Not A Competitor At All'...
5	SFTBY, TSLA: Lucid In Talks With Saudi Arabi...
6	AAPL, MSFT: Why Tesla's Q4 E...
7	GME: Unusual Options Ac...

1	BB: Why BlackBerry's Stock Is Trading Higher Today
2	GME: Market Pros On GameStop: 'Wall Street Shouldn't Be Proud'
3	Preferred Stock, Understanding Critical Components
4	TSLA: Tesla Loses Engineer That Helped Bring Efficiency Boosting Heat Pump
5	ROKU: 7 Reasons Why Roku's Stock Can Rise To $500
6	VZ, MMM: This Earnings Week Will Be A Busy One
7	LCY, HD: Leading Fastener, Hardware Company Hillman Group Land...